tenk.fyi

SELLAS Life Sciences Group, Inc.

SLSNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$26.9M

13.0% YoY

EPS

$-0.25

50.0% YoY

Cash

$71.8M

417.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro